These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 23070104
1. Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study. Chalmers N, Walker PT, Belli AM, Thorpe AP, Sidhu PS, Robinson G, van Ransbeeck M, Fearn SA. Cardiovasc Intervent Radiol; 2013 Apr; 36(2):353-61. PubMed ID: 23070104 [Abstract] [Full Text] [Related]
2. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Chowdhury MM, McLain AD, Twine CP. Cochrane Database Syst Rev; 2014 Jun 24; 2014(6):CD006767. PubMed ID: 24959692 [Abstract] [Full Text] [Related]
3. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial. Karimi A, de Boer SW, van den Heuvel DA, Fioole B, Vroegindeweij D, Heyligers JM, Lohle PN, Elgersma O, Nolthenius RP, Vos JA, de Vries JP. Trials; 2013 Mar 28; 14():87. PubMed ID: 23537403 [Abstract] [Full Text] [Related]
9. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2010 Jul 17; 10(18):1-88. PubMed ID: 23074395 [Abstract] [Full Text] [Related]
12. Predictive factors of femoropopliteal patency after suboptimal duplex-guided balloon angioplasty and stenting: is recoil a bad sign? Ascher E, Hingorani AP, Marks N, Puggioni A, Shiferson A, Tran V, Jacob T. Vascular; 2008 Jul 17; 16(5):263-8. PubMed ID: 19238867 [Abstract] [Full Text] [Related]
15. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Circulation; 2007 May 29; 115(21):2745-9. PubMed ID: 17502568 [Abstract] [Full Text] [Related]
16. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills JL, Goshima KR, Echeverri JA, Arslan B. J Vasc Surg; 2008 May 29; 47(5):967-74. PubMed ID: 18372147 [Abstract] [Full Text] [Related]
18. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F. JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1386-92. PubMed ID: 27388828 [Abstract] [Full Text] [Related]